Iridius offers a platform composed of a knowledge engine that breaks regulations down rule-by-rule for real-time queries by AI agents and a solution factory that helps customers design, build, and connect compliant AI workflows to existing enterprise systems. The company's initial focus is life sciences and pharmaceutical customers, where it targets detailed compliance, validation, and audit requirements. Iridius was founded in 2024 by Mike Kropp and Alistair Lowe-Norris and has a leadership team with veterans from Microsoft, AWS, OpenAI, and Amazon. The startup has assembled an advisory bench of former CIOs from major pharma and medtech companies and added Clark Golestani, former Merck CIO, to its board. Iridius has not yet commercially launched its product but has a signed co-development agreement with a pharmaceutical customer and is in active discussions with others. Following its $8.6M seed raise, the company is expanding hiring, particularly for its AI engineering team.

Total raised

$9M

Funding rounds

1

Latest round

Seed

Latest activity

Apr 2026